{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:09:14Z","timestamp":1792570154304,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Infection of humans with <jats:italic>Chlamydia trachomatis<\/jats:italic>, a bacterial pathogen with a unique intracellular replication cycle, may cause a variety of clinical manifestations. These are linked to various serovars of the pathogen; trachoma to serovars A-C, oculogenital infections to serovars D-K, and lymphogranuloma venereum to serovars L1-L3. Nineteen serovars are known as human pathogens. The aim of the study was to determine the serovars of 401\u2009<jats:italic>C. trachomatis<\/jats:italic> DNA positive extracts from original clinical specimens of patients in Austria including cervical and urethral swabs, urine, genital secretions and conjunctival swabs - collected from 2014 to 2017. Sequence analysis of the omp1 gene, encoding major outer-membrane protein was performed on each sample. In 50.1% of samples serovar E was identified and serovars F, D\/Da and G\/Ga were found in 16.2%, 9.7% and 9.0%, respectively. Remaining serovars were J (6.0%), K (4.7%), H (2.7%), B\/Ba (1.0%), and I\/Ia (0.5%). In 19 patients follow up samples could be tested. The majority of <jats:italic>C. trachomatis<\/jats:italic> serovars were associated with urogenital tract infections (D-K), however, one of them \u2013 serovar B\/Ba - is linked to both, ocular and genital tract infection.<\/jats:p>","DOI":"10.1038\/s41598-019-54886-5","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T11:02:34Z","timestamp":1575457354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Chlamydia trachomatis serovars in urogenital and ocular samples collected 2014\u20132017 from Austrian patients"],"prefix":"10.1038","volume":"9","author":[{"given":"Iwona","family":"Lesiak-Markowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Margarita","family":"Sch\u00f6tta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Stockinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerold","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Markowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"54886_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1371\/journal.pone.0143304","volume":"10","author":"L Newman","year":"2015","unstructured":"Newman, L. et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systemic review and global reporting. PLoS One. 10, 12, https:\/\/doi.org\/10.1371\/journal.pone.0143304 (2015).","journal-title":"PLoS One."},{"key":"54886_CR2","unstructured":"European Center for Disease Prevention and Control. Sexually transmitted infections in Europe 2013. Stockholm: ECDC, htpp:\/\/ecdc.europa.eu\/en\/publications\/Publications\/sexual-transmitted-infections-europe-surveillance-report-2013.pd (2015)"},{"key":"54886_CR3","unstructured":"CDC. Sexually Transmitted Disease Surveillance 2012. Atlanta: U.S. Department of Health and Human Science, htpp:\/\/www.cdc.gov\/sTD\/stats12\/Surv2012.pdf (2013)"},{"key":"54886_CR4","first-page":"303","volume":"138","author":"M Malhotra","year":"2013","unstructured":"Malhotra, M., Sood, S., Mukherjee, A., Muralidhar, S. & Bala, M. Genital Chlamydia trachomatis: an update. Indian J Med Res. 138, 303\u201316 (2013).","journal-title":"Indian J Med Res."},{"key":"54886_CR5","doi-asserted-by":"crossref","unstructured":"Schachter J. Infection and disease epidemiology. In: Stephens RS, ed. Chlamydia. Washington, DC: ASM Press 139\u201369 (1999)","DOI":"10.1128\/9781555818203.ch6"},{"key":"54886_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/infdis\/152.4.791","volume":"152","author":"SP Wang","year":"1985","unstructured":"Wang, S. P., Kuo, C. C., Barnes, R. C., Stephens, R. S. & Grayston, J. T. Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis. 152, 791\u2013800 (1985).","journal-title":"J Infect Dis."},{"key":"54886_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jinf.2005.08.019","volume":"52","author":"G Lee","year":"2006","unstructured":"Lee, G. et al. ompA genotyping of Chlamydia trachomatis from Korean female sex workers. J Infect. 52, 451\u2013454 (2006).","journal-title":"J Infect."},{"key":"54886_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1099\/jmm.0.026476-0","volume":"60","author":"AC Machado","year":"2011","unstructured":"Machado, A. C. et al. Distribution of Chlamydia trachomatis genovars among youths and adults in Brazil. J Med Microbiol. 60, 472\u2013476 (2011).","journal-title":"J Med Microbiol."},{"key":"54886_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0002-9394(70)90096-6","volume":"70","author":"SP Wang","year":"1970","unstructured":"Wang, S. P. & Grayston, J. T. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol. 70, 367\u2013374 (1970).","journal-title":"Am J Ophthalmol."},{"issue":"10","key":"54886_CR10","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1111\/jdv.15729","volume":"33","author":"H.J.C. de Vries","year":"2019","unstructured":"de Vries H. et al. 2019 European guideline on the management of lymphogranuloma venereum. J Eur Acad Dermatol Venereol., https:\/\/doi.org\/10.1111\/jdv.15729 (2019)","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"54886_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1099\/jmm.0.46262-0","volume":"55","author":"Mc Hsu","year":"2006","unstructured":"Hsu, Mc et al. Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan. J Med Microbiol. 55, 301\u20138 (2006).","journal-title":"J Med Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54886-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:57:59Z","timestamp":1671296279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-54886-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["54886"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-54886-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"28 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18327"}}